BioMarin Pharmaceutical, Inc. (BMRN)
57.24
+0.75
(+1.33%)
USD |
NASDAQ |
Apr 01, 16:00
57.23
-0.01
(-0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Research and Development Expense (TTM) : 700.97M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 135.84M |
| Ionis Pharmaceuticals, Inc. | 914.12M |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| MannKind Corp. | 66.35M |
| Terns Pharmaceuticals, Inc. | 77.89M |